In vitro activities of daptomycin (LY146032) and paldimycin (U-70,138F) against anaerobic gram-positive bacteria
- 1 May 1988
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 32 (5), 788-790
- https://doi.org/10.1128/aac.32.5.788
Abstract
The in vitro activities of daptomycin (LY146032), paldimycin (U-70,138F), vancomycin, and penicillin G against 344 clinical isolates of anaerobic gram-positive bacteria were determined by an agar dilution method in calcium-supplemented (50 .mu.g/ml) Wilkins-Chalgren medium, using an inoculum of 105 CFU. Daptomycin demonstrated excellent activity against a broad range of anaerobic gram-positive cocci and bacilli, including Peptostreptococcus, Eubacterium, Bifidobacterium, Actinomyces, Propionibacterium, and Lactobacillus species and Clostridium difficile. Highly resistant strains (MIC, .gtoreq. 64 .mu.g/ml) were encountered sporadically from different genera, but these accounted for only 3% of all isolates tested. Vancomycin showed similar activity but was less active against Lactobacillus species and Peptostreptococcus prevotii. Paldimycin was inactive against most genera of anaerobic gram-positive bacteria. Overall, penicillin G remained the most broadly active agent against these isolates.This publication has 13 references indexed in Scilit:
- Treatment of Clostridium difficile colitis in hamsters with a lipopeptide antibiotic, LY146032Antimicrobial Agents and Chemotherapy, 1987
- Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032Antimicrobial Agents and Chemotherapy, 1987
- Bactericidal activity of deptomycin (LY146032) compared with those of ciprofloxacin, vancomycin, and ampicillin against enterococci as determined by kill-kinetic studiesAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity of paldimycin (U-70138F) against gram-positive bacteria isolated from patients with cancerAntimicrobial Agents and Chemotherapy, 1987
- Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendationsAntimicrobial Agents and Chemotherapy, 1987
- Effect of calcium on in vitro activity of LY146032 against Clostridium difficileAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity of a new cyclic lipopeptide antibiotic, LY146032, against gram-positive clinical bacteriaAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocciAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity of LY146032 against staphylococci, streptococci, and enterococciAntimicrobial Agents and Chemotherapy, 1986
- In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibioticAntimicrobial Agents and Chemotherapy, 1986